FFIV

F5 is executing exceptionally well after the post-pandemic digestion period. FY2025 revenue grew 9.7% to $3.09B, but the mix shift is the real story: product revenue jumped 18.5% (systems +31.3%, software +9.2%) as MD&A notes 'improving customer demand, which began to stabilize and improve following macroeconomic uncertainties at the start of fiscal 2024.' Gross margin expanded to 81.4% from 80.2%, operating margin hit 24.8%, and net income surged 22.2% to $692M — a textbook operating-leverage cycle. The balance sheet is fortress-grade: $1.34B cash, zero long-term debt (per FY2022 disclosure), liabilities/equity of 0.45x, and $950M of operating cash flow funded $502M of buybacks while shares shrank only modestly (-0.9%), suggesting SBC dilution offset.

The quality is unambiguous: 19.3% ROE, 81% gross margins, and a clear pivot toward higher-quality recurring revenue (subscription software now $508M, +18% YoY) while legacy perpetual licenses fade to just 7.9% of product mix. R&D spend rose 10.1% to $540M (17.5% of revenue), preserving the innovation budget. The hardware refresh cycle that drove systems +31.3% is, however, partly a tailwind that won't repeat at the same magnitude — MD&A frames it as demand normalization plus pricing, not a structural step-change.